Video
2 Sep 2020

Pharmaceutical Industry in Korea 2020

Korean pharmaceutical and biopharmaceutical industry is expected to lead the global market, as globally competitive products and innovative technologies are being developed every day. Drug development capabilities and rapid globalization of K-Pharma make the industry very promising for the future.

Content provided by our supplier

Korea Health Industry Development Institute

  • KR
  • 2020
    On CPHI since

Other Content from Korea Health Industry Development Institute (3)

  • Brochure Pharmaceutical Industry in Korea 2020

    Korean pharmaceutical and biopharmaceutical industry is expected to lead the global market, as globally competitive products and innovative technologies are being developed every day. Drug development capabilities and rapid globalization of K-Pharma make the industry very promising for the future.
  • Video Korea: Innovation & R&D Trends

    This session will focus on the latest developments in the Korean biopharmaceutical market and look in-depth at R&D trends. Korea has emerged as a leading biopharmaceutical market, valued at around $18.6 billion with a annual growth rate of 7% from 2012 to 2018. Furthermore, the domestic biopharmaceutical industry is expanding internationally with the advancement of innovative technologies and has become a key growth engine for the Pharma industry in Korea. hear from global consultants on the strengths of Korea's Biopharma industry, who will share practical information and data on R&D, RA, Business Development and Marketing strategies. This is a great opportunity to gain cutting-edge insight from businesses who are scaling up for the future and building partnerships with domestic pharmaceutical companies. - Peptron : Smart Depot Platform and its applications - Olix Pharmaceuticals : OliX Pharmaceuticals: RNAi Therapeutics Company - HK inno.N : World P-CAB Leader, HK inno.N - Daewoong Pharmaceutical : Research & Development innovation with Daewoong's Platform Technology - Huons : Huons Corporate Presentation: Hu007 and Hutox - Ceres F&D : Introduction of Hyaluronidase and Tacrolimus Aired as part of the CPHI Festival of pharma
  • Video Korean pharmaceutical companies' IR Session

    Korea Health Industry Development Insititute(KHIDI) has prepared Korean IR session in order to enable Korean pharmaceutical companies to expand opportunity to enter into global market and have business meeting with other countries.2 foreign principal consultants in KHIDI provide brief explanation of Korean pharmaceutical industry and 6 companies introduce their company and their innovative technology and project. 
    You can meet their distinctive presentation below the google link.